Enrolment of Older Adults Begins In COVID-19 Vaccine Clinical Trial
Emory University (Atlanta, GA, USA) has begun enrolling adults aged over 55 years in the clinical trial of an investigational vaccine designed to prevent coronavirus disease 2019 (COVID-19). Enrolling older adult volunteers will help investigators better understand vaccination outcomes among older people, who face a higher risk of complications from COVID-19 than younger individuals. More...22 Apr 2020
Rockefeller Foundation Lays Out Massive COVID-19 Testing Action Plan for US
The Rockefeller Foundation (New York, NY, USA) has laid out a National COVID-19 Testing Action Plan which outlines the precise steps necessary to enact robust testing, tracing, and coordination to more safely reopen the US economy – starting with a dramatic expansion of testing from one million tests per week to initially three million per week and then 30 million per week. More...22 Apr 2020
MedTest Dx Offers Only FDA Approved Quantitative Test for G6PD Status of COVID-19 Patients
MedTest Dx, Inc. (Canton, MI, USA), a solution provider for clinical diagnostic testing, is offering its Pointe Scientific-branded assay for the highly sensitive quantification of G6PD in whole blood. More...22 Apr 2020
COVID-19 Vaccine Candidate Based on Engineered Dog Virus Shows Promise in Promoting Immune Response
Researchers at the University of Georgia (Athens, GA, USA) College of Veterinary Medicine has developed a COVID-19 vaccine candidate that has proven successful in promoting an immune response in early test models. More...22 Apr 2020
Randox Unveils Whole Pathogen Molecular Controls for SARS-CoV-2 (COVID-19)
Randox Laboratories (Crumlin, UK) has developed whole pathogen quality controls to support accurate coronavirus testing. The molecular controls are currently being used as part of a nationwide testing program for frontline NHS workers. More...22 Apr 2020
First US COVID-19 Patient Treated with Artificial Antibody in Clinical Trial
Temple University Hospital (Philadelphia, PA, USA) has treated the first patient in the US in the BREATHE clinical trial evaluating the impact of intravenous treatment with gimsilumab on mortality for patients with COVID-19 and acute respiratory distress syndrome (ARDS). More...21 Apr 2020
In Other News
Novel Vaccine Design Targeting Coronavirus’ Achilles’ Heel Granted US Patent
Vela Diagnostics Awarded BARDA Contract to Develop Manual and Automated COVID-19 Tests
NIH Announces Public-Private Partnership to Speed COVID-19 Vaccine and Treatment
GenoSensor COVID-19 RT-PCR KIT Granted FDA Emergency Use Authorization
ELITechGroup’s Rapid Detection Test Kits Secure FDA Emergency Use Authorization
Novartis to Begin Phase III Clinical Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients
Gilead’s Antiviral Remdesivir Prevents Disease Progression in Monkeys with COVID-19
Coronavirus-Detecting Breathing Device Could Potentially Give a Diagnosis in Less than One Minute
COVID-19 Microneedle Vaccine Delivery Could Enhance Efficiency and Reduce Dose
Accelerate Diagnostics Partners with BioCheck to Distribute CLIA Analyzer and SARS-CoV-2 Antibody Tests
Gilead's Remdesivir Could Stop SARS-CoV-2 from Replicating, Find Researchers
Newly Launched Coronavirus Blood Test Identifies Past Exposure
Gold Standard Diagnostics Launches COVID-19 Antibody Tests
New CRISPR-Based Test Diagnoses COVID-19 Infection in Less than an Hour
Rutgers Secures US FDA Emergency Use Authorization for New Coronavirus Saliva Test
COVID-19: 155 Drugs and 79 Vaccines Currently Under Development Worldwide
RT-LAMP Assay Developed for SARS-CoV-2
Vast Majority of Coronavirus Infections Go Undetected
3D-Printed Connectors Could Alleviate Ventilator Shortage
Pioneering Technique Converts Non-Invasive Ventilators into Advanced Invasive Ventilators for Treating COVID-19
Nova Biomedical to Host Webinar on COVID-19 Bedside Glucose Management
AI Platform Identifies Top Candidate Drugs for Treatment of COVID-19
Sense Accelerates World’s First Instrument-Free, POC Molecular Diagnostic Test for COVID-19